These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9189719)

  • 1. Molecular pathology of prion diseases.
    Smith C; Collinge J
    Essays Biochem; 1995; 29():157-74. PubMed ID: 9189719
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular modelling indicates that the pathological conformations of prion proteins might be beta-helical.
    Downing DT; Lazo ND
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):453-60. PubMed ID: 10510313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation.
    Cappai R; Stewart L; Jobling MF; Thyer JM; White AR; Beyreuther K; Collins SJ; Masters CL; Barrow CJ
    Biochemistry; 1999 Mar; 38(11):3280-4. PubMed ID: 10079070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between prion diseases and conformational transition of peptides].
    Yanagawa H; Ogawa Y
    Tanpakushitsu Kakusan Koso; 2001 Aug; 46(11 Suppl):1789-97. PubMed ID: 11579580
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantifying the sequence-dependent species barrier between hamster and mouse prions.
    Lee LY; Chen RP
    J Am Chem Soc; 2007 Feb; 129(6):1644-52. PubMed ID: 17243682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein misfolding and prion diseases.
    Cohen FE
    J Mol Biol; 1999 Oct; 293(2):313-20. PubMed ID: 10550211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insight into the species barrier of mammalian prions obtained from structure-based conservation analysis.
    Wang Y; Hu B; Liu Y; Zhang H; Song Y
    Intervirology; 2008; 51(3):210-6. PubMed ID: 18753795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid sequence of the Pekingese dog prion protein gene.
    Wu C; Pang W; Yang J; Zhou X; Zhao D
    Xenotransplantation; 2006 Sep; 13(5):471-4. PubMed ID: 16925672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered toxicity of the prion protein peptide PrP106-126 carrying the Ala(117)-->Val mutation.
    Brown DR
    Biochem J; 2000 Mar; 346 Pt 3(Pt 3):785-91. PubMed ID: 10698707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why are prion diseases precluded by non-mammals?
    Ji HF; Zhang HY; Chen LL
    Trends Biochem Sci; 2007 May; 32(5):206-8; discussion 208. PubMed ID: 17419063
    [No Abstract]   [Full Text] [Related]  

  • 11. Prion diseases in man.
    Ironside JW
    J Pathol; 1998 Nov; 186(3):227-34. PubMed ID: 10211109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into prion strains and neurotoxicity.
    Aguzzi A; Heikenwalder M; Polymenidou M
    Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chicken prion tandem repeats form a stable, protease-resistant domain.
    Marcotte EM; Eisenberg D
    Biochemistry; 1999 Jan; 38(2):667-76. PubMed ID: 9888807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prions].
    Scheffer U
    Med Klin (Munich); 1995 Nov; 90(11):653-7. PubMed ID: 8569634
    [No Abstract]   [Full Text] [Related]  

  • 15. The reconstitution of mammalian prion infectivity de novo.
    Baskakov IV
    FEBS J; 2007 Feb; 274(3):576-87. PubMed ID: 17288547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231.
    Apetri AC; Vanik DL; Surewicz WK
    Biochemistry; 2005 Dec; 44(48):15880-8. PubMed ID: 16313190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
    Liemann S; Glockshuber R
    Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of cerebral neurodegeneration in prion diseases.
    Tatzelt J; Schätzl HM
    FEBS J; 2007 Feb; 274(3):606-11. PubMed ID: 17288549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
    Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
    Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion protein structure and scrapie replication: theoretical, spectroscopic, and genetic investigations.
    Bamborough P; Wille H; Telling GC; Yehiely F; Prusiner SB; Cohen FE
    Cold Spring Harb Symp Quant Biol; 1996; 61():495-509. PubMed ID: 9246476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.